Number | Cited Articles |
1 |
Peng‐sheng Ting, James Peter Hamilton, Ahmet Gurakar, Nathalie H. Urrunaga, Michelle Ma, Jaime Glorioso, Elizabeth King, Lindsey P. Toman, Russell Wesson, Jacqueline Garonzik‐Wang, Shane Ottmann, Benjamin Philosophe, Mark Sulkowski, Andrew M. Cameron, Christine M. Durand, Po‐Hung Chen. Hepatitis C‐positive donor liver transplantation for hepatitis C seronegative recipients. Transplant Infectious Disease 2019; 21(6) doi: 10.1111/tid.13194
|
2 |
Myra Nasir, George Y. Wu. Prevention of HBV Recurrence after Liver Transplant: A Review. Journal of Clinical and Translational Hepatology 2020; 8(2): 150 doi: 10.14218/JCTH.2020.00003
|
3 |
Kali Zhou, Selena Zhou. Risk of disease transmission in an expanded donor population: the potential of hepatitis B virus donors. Current Opinion in Organ Transplantation 2020; 25(6): 631 doi: 10.1097/MOT.0000000000000810
|
4 |
James S. Park, Vijay Gayam, Calvin Q. Pan. Review article: preventing hepatitis B graft infection in hepatitis B patients after liver transplantation: immunoglobulin vs anti-virals. Alimentary Pharmacology & Therapeutics 2020; doi: 10.1111/apt.15999
|
5 |
Robert G. Gish, Syed Abdul Basit, John Ryan, Altaf Dawood, Ulrike Protzer. Hepatitis B Core Antibody: Role in Clinical Practice in 2020. Current Hepatology Reports 2020; 19(3): 254 doi: 10.1007/s11901-020-00522-0
|